Remote monitoring may Fine-Tune heart failure meds faster

NCT ID NCT07518030

Recruiting now Disease control Sponsor: Azienda Unita Sanitaria Locale di Piacenza Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether telemedicine follow-up helps doctors adjust heart failure medications more effectively than standard in-person visits. Eighty adults with newly diagnosed heart failure with reduced ejection fraction will be randomly assigned to either remote monitoring or usual care. The main goal is to see if the telemedicine group achieves better medication optimization after six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: telemedicine-based follow-up
What this could lead to: If successful, this could show that remote monitoring and virtual check-ins help doctors fine-tune heart failure medications more quickly and safely than standard in-person visits.
What could go wrong: This is a small, early-stage trial with only 80 participants, so results may not apply to everyone. Telemedicine may not work as well for patients with limited digital skills or access.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)

Contacts and locations

Locations

Clinical Research Office, AUSL Piacenza
RECRUITING

Piacenza, 29121, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.